---
figid: PMC6373401__40263_2018_601_Fig1_HTML
figlink: /pmc/articles/PMC6373401/figure/Fig1/
number: Fig. 1
caption: Potential neuroprotective mechanisms of antidiabetic drugs in the context
  of Parkinson’s disease dementia. ChIs block ACh degradation by ChE allowing ACh
  to bind to either the mAChR or nicotinic receptors resulting in MAP kinase signalling.
  IGF-1 or insulin bind to the IR activating MAP kinase signalling, promoting cell
  growth and synaptic plasticity via BDNF, or the PI3 K/AKT signalling pathway, resulting
  in cell proliferation and survival via modulating multiple downstream targets including
  mTOR, GSK-3β, FoxO and NFκB. DPP-IV inhibitors block the degradation of GLP-1 by
  DDP-IV, promoting signalling, while GLP-1 analogues directly promote GLP-1R signalling,
  which increases cAMP activating of the aforementioned signalling pathways and also
  activates the PKA signalling pathway resulting in the activation of CREB and resultant
  gene transcription. Proinflammatory cytokines, which are elevated in Parkinson’s
  disease, such as TNFα and IL-1 promote pro-inflammatory cytokine release via NFκB
  signalling and can also inhibit insulin and IGF-1 signalling, resulting in the disruption
  of MAP kinase and PI3 K signalling. In contrast to this, glitazones can activate
  PPARγ, resulting in gene transcription of neuroprotective mediators. PGC-1α can
  bind to various transcription factors including PPARγ and exerts a neuroprotective
  effect. The insulin degrading enzyme can target α-syn, binding to α-syn oligomers
  inhibiting the formation of fibrils. α-syn alpha-synuclein, ACh acetylcholine, AKT
  protein kinase B, ChE cholinesterase, ChI cholinesterase inhibitor, BDNF brain-derived
  neurotrophic factor, cAMP cyclic adenosine monophosphate, CREB cyclic adenosine
  monophosphate response element-binding protein, DPP-IV dipeptidyl peptidase IV,
  FoxO forkhead box O, GLP-1 glucagon-like peptide-1, GLP1R glucagon-like peptide-1
  receptor, GSK3β glycogen synthase kinase-3β, IDE insulin degrading enzyme, IGF-1
  insulin growth factor-1, IL-1 interleukin-1, IR insulin receptor, mAChR muscarinic
  acetylcholine receptors, MAP mitogen-activated protein, mTOR mammalian target of
  rapamycin, NFκB nuclear factor-κB, PI3 K phosphatidylinositol 3 kinase pathway,
  PGC-1α PPARγ coactivator 1α, PKA protein kinase A, PPARγ proliferator-activated
  receptor-γ, TNFα tumour necrosis factor-α
pmcid: PMC6373401
papertitle: Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s
  Disease with an Emphasis on Diabetes-Related Pathways.
reftext: Holly Green, et al. CNS Drugs. 2019;33(2):143-160.
pmc_ranked_result_index: '7943'
pathway_score: 0.9506104
filename: 40263_2018_601_Fig1_HTML.jpg
figtitle: Neuroprotective mechanisms of antidiabetic drugs in the context of Parkinson’s
  disease dementia
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6373401__40263_2018_601_Fig1_HTML.html
  '@type': Dataset
  description: Potential neuroprotective mechanisms of antidiabetic drugs in the context
    of Parkinson’s disease dementia. ChIs block ACh degradation by ChE allowing ACh
    to bind to either the mAChR or nicotinic receptors resulting in MAP kinase signalling.
    IGF-1 or insulin bind to the IR activating MAP kinase signalling, promoting cell
    growth and synaptic plasticity via BDNF, or the PI3 K/AKT signalling pathway,
    resulting in cell proliferation and survival via modulating multiple downstream
    targets including mTOR, GSK-3β, FoxO and NFκB. DPP-IV inhibitors block the degradation
    of GLP-1 by DDP-IV, promoting signalling, while GLP-1 analogues directly promote
    GLP-1R signalling, which increases cAMP activating of the aforementioned signalling
    pathways and also activates the PKA signalling pathway resulting in the activation
    of CREB and resultant gene transcription. Proinflammatory cytokines, which are
    elevated in Parkinson’s disease, such as TNFα and IL-1 promote pro-inflammatory
    cytokine release via NFκB signalling and can also inhibit insulin and IGF-1 signalling,
    resulting in the disruption of MAP kinase and PI3 K signalling. In contrast to
    this, glitazones can activate PPARγ, resulting in gene transcription of neuroprotective
    mediators. PGC-1α can bind to various transcription factors including PPARγ and
    exerts a neuroprotective effect. The insulin degrading enzyme can target α-syn,
    binding to α-syn oligomers inhibiting the formation of fibrils. α-syn alpha-synuclein,
    ACh acetylcholine, AKT protein kinase B, ChE cholinesterase, ChI cholinesterase
    inhibitor, BDNF brain-derived neurotrophic factor, cAMP cyclic adenosine monophosphate,
    CREB cyclic adenosine monophosphate response element-binding protein, DPP-IV dipeptidyl
    peptidase IV, FoxO forkhead box O, GLP-1 glucagon-like peptide-1, GLP1R glucagon-like
    peptide-1 receptor, GSK3β glycogen synthase kinase-3β, IDE insulin degrading enzyme,
    IGF-1 insulin growth factor-1, IL-1 interleukin-1, IR insulin receptor, mAChR
    muscarinic acetylcholine receptors, MAP mitogen-activated protein, mTOR mammalian
    target of rapamycin, NFκB nuclear factor-κB, PI3 K phosphatidylinositol 3 kinase
    pathway, PGC-1α PPARγ coactivator 1α, PKA protein kinase A, PPARγ proliferator-activated
    receptor-γ, TNFα tumour necrosis factor-α
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CREM
  - ATF1
  - CREB3L2
  - RELB
  - CREB3L4
  - PIK3R6
  - RELA
  - PIK3R4
  - CXCL2
  - CXCL3
  - PIK3R5
  - CXCL10
  - CXCL9
  - PF4
  - CXCL8
  - REL
  - AKT2
  - PPARGC1A
  - CXCL5
  - CXCL13
  - CXCL1
  - CREB1
  - ATF2
  - PRKAR2A
  - PRKAR2B
  - PPARA
  - CREB3L3
  - CREB3L1
  - CREB5
  - FOXO6
  - BDNF
  - CXCL14
  - CHRDL1
  - CREB3
  - IDE
  - IGF1
  - IL1A
  - IL1B
  - IL1R1
  - MTOR
  - NFKB1
  - NFKB2
  - FGFR3
  - AKT3
  - AKT1
  - PRKACA
  - PRKACB
  - PRKACG
  - PRKAR1A
  - PRKAR1B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PPBP
  - CXCL6
  - CXCL11
  - CXCL12
  - FOXO3
  - FOXO4
  - GLP1R
  - TNFRSF1A
  - PPARD
  - PPARG
  - TNF
  - FOXO1
  - PIK3R3
  - Rivastigmine
  - donepezil
  - Ga
  - Sitagliptin
  - Glitazones
  - Cancer
genes:
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PGC-1a
  symbol: PGC-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: Chls
  symbol: CHL
  source: hgnc_alias_symbol
  hgnc_symbol: CHRDL1
  entrez: '91851'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: IDE
  symbol: IDE
  source: hgnc_symbol
  hgnc_symbol: IDE
  entrez: '3416'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-1R1
  symbol: IL1R1
  source: hgnc_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: ACh
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: chemokines,
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: GLP-1R
  symbol: GLP-1R
  source: hgnc_alias_symbol
  hgnc_symbol: GLP1R
  entrez: '2740'
- word: TNFR1
  symbol: TNFR1
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARD
  entrez: '5467'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARG
  entrez: '5468'
- word: TNFA
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
chemicals:
- word: Rivastigmine
  source: MESH
  identifier: C072506
- word: donepezil
  source: MESH
  identifier: C076946
- word: Ga
  source: MESH
  identifier: C043055
- word: Sitagliptin
  source: MESH
  identifier: C496398
- word: Glitazones
  source: MESH
  identifier: D045162
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
